BEAT HeartBeam Inc: יחס שווי שוק לערך בספרים

The current price chart for HeartBeam, Inc. (BEAT) demonstrates the impact of the rollout of compact 3D-ECG sensors and AI-driven software for myocardial infarction diagnostics. The current metric stands at 2.71 as the company pursues FDA certification for its cardio-maps. The business relies on telemedicine, which ignores market cycles and seasonality, providing high defensive qualities for assets amidst any economic turmoil.

HeartBeam, Inc. (BEAT) develops AI-powered ECG systems and is currently in the regulatory approval stage with no current revenue. The mvsbcap_co indicator compares market capitalization to net assets, measuring the premium attributed to future technologies. By analyzing the current market-to-book ratio on GURU.Markets, investors can separate speculative noise from the fundamental trend. This price action reflects the business's dependence on external financing, where high values signal a capital overvaluation relative to tangible resources.